MRI radiomics shows potential in determining breast cancer HER2 status
AuntMinnie
JANUARY 25, 2024
Researchers led by Yuqin Peng from Sun Yat-Sen Memorial Hospital, Sun Yat-Sen University in Guangzhou, Guangdong found that their nomogram based on MRI radiomics can distinguish HER2-zero from HER2-low or HER2-positives cancers, as well as HER2-low from HER2-positive cancers. The women underwent breast MRI between 2016 and 2022.
Let's personalize your content